<DOC>
	<DOCNO>NCT00200707</DOCNO>
	<brief_summary>Emerging evidence suggest stem cell progenitor cell derive bone marrow use improve cardiac function patient acute myocardial infarction . In randomised trial , aim ass whether intracoronary transfer autologous bone-marrow cell could improve myocardial viability 3 12 month ' follow-up .</brief_summary>
	<brief_title>BONAMI ( BOne Marrow Acute Myocardial Infarction )</brief_title>
	<detailed_description>After successful percutaneous coronary intervention ( PCI ) acute myocardial infarction , 100 patient randomly assign either control group ( n=50 ) receive optimal medical treatment , bone-marrow-cell group ( n=50 ) receive optimal medical treatment intracoronary transfer autologous bone-marrow cell 7â€¢10 day PCI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Men woman 1875 year . Acute myocardial infarction Absence viability infarcted zone LVEF &lt; 45 % . History prior myocardial infarction Significant stenosis another coronary territory acutely treat vessel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Cell therapy</keyword>
	<keyword>bone marrow mononuclear cell</keyword>
	<keyword>myocardial infarction</keyword>
</DOC>